+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Anthrax Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767659
  • Report
  • April 2019
  • Region: Global
  • 57 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Elusys Therapeutics Inc
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • IQVIA Holdings Inc
  • Jean Brown Research
  • Medarex Inc
  • MORE
The global clinical trial report- “2019 Anthrax Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Anthrax. It presents in-depth analysis of Anthrax clinical trials across markets and companies. The research work is for providing complete understanding into trends in Anthrax.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Anthrax clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Anthrax

The research work is prepared through extensive and continuous research on Anthrax trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Anthrax patients are identified
  • The report includes panorama of Anthrax clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Anthrax clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Elusys Therapeutics Inc
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • IQVIA Holdings Inc
  • Jean Brown Research
  • Medarex Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Anthrax Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Anthrax Clinical Trials by Region
2.2.2 Average Enrollment of Anthrax Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Anthrax Treatment, 2019

3. Region wise Anthrax Clinical Trials
3.1 Asia Pacific Anthrax Clinical Trials by Country
3.2 Europe Anthrax Clinical Trials by Country
3.3 North America Anthrax Clinical Trials by Country
3.4 Middle East and Africa Anthrax Clinical Trials by Country
3.5 South and Central America Anthrax Clinical Trials by Country

4. Anthrax Clinical Trial Trends
4.1 Start Year wise Anthrax Clinical Trials
4.2 Phase wise Anthrax Clinical Trials
4.3 Trial Status wise Anthrax Clinical Trials
4.4 Trial Type wise Anthrax Clinical Trials

5. Anthrax Average Enrollment Trends
5.1 Average Enrollment in Anthrax Trials by Year
5.2 Average Enrollment in Anthrax Trials by Phase
5.3 Average Enrollment in Anthrax Trials by Status
5.4 Average Enrollment in Anthrax Trials by Type of Trial

6. Companies Participating in Anthrax Clinical Trials
6.1 Anthrax Trials by Sponsor Type
6.2 Anthrax Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Anthrax Trials- Phase 1
7.2 Anthrax Trials- Phase 2
7.3 Anthrax Trials- Phase 3
7.4 Anthrax Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Anthrax Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Anthrax Clinical Trials and Enrolment
Figure 5: Europe - Country wise Anthrax Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Anthrax Clinical Trials and Enrolment
Figure 7: North America - Country wise Anthrax Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Anthrax Clinical Trials and Enrolment
Figure 9: Anthrax Clinical Trials by Phase
Figure 10: Anthrax Clinical Trials by Trial Status
Figure 11: Anthrax Clinical Trials by Type
Figure 12: Anthrax Clinical Trials by Sponsor Type
Figure 13: Anthrax Clinical Trials by Leading Sponsors
Figure 14: Anthrax Average Enrollment by Phase
Figure 15: Anthrax Average Enrollment by Trial Status
Figure 16: Anthrax Average Enrollment by Type
Figure 17: Anthrax- Average Enrolment by Type of Sponsors
Figure 18: Anthrax- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Anthrax Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Anthrax Clinical Trials and Enrolment
Table 5: Europe - Country wise Anthrax Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Anthrax Clinical Trials and Enrolment
Table 7: North America - Country wise Anthrax Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Anthrax Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Anthrax Average Enrollment by Phase
Table 15: Anthrax Average Enrollment by Trial Status
Table 16: Anthrax Average Enrollment by Type
Table 17: Anthrax- Average Enrolment by Type of Sponsors
Table 18: Anthrax- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Elusys Therapeutics Inc
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • IQVIA Holdings Inc
  • Jean Brown Research
  • Medarex Inc
  • Pfenex Inc
  • Pharmaceutical Product Development LLC
  • PharmAthene Inc
  • QPS Holdings LLC
Note: Product cover images may vary from those shown
Adroll
adroll